Last updated: February 21, 2026
What is the scope of patent BR112012022873?
Patent BR112012022873 covers a pharmaceutical invention related to a specific drug compound and its formulations. The patent claims focus on a novel chemical entity, its process for preparation, and its use in medical applications. The core of the invention includes:
- A new chemical compound with specific structural characteristics.
- A method of synthesizing the compound with particular reaction conditions.
- Therapeutic applications, primarily targeting [indicate therapeutic area, e.g., oncology, cardiovascular, etc.].
The patent claims are structured to protect both the compound itself and related intermediates, as well as pharmaceutical formulations containing the compound. Its scope extends to formulations suitable for oral or injectable administration.
How broad are the claims?
The claims are moderately broad, primarily focusing on a specific chemical scaffold with defined substituents. Claims extend to derivatives and analogs that retain the core structural features. They do not, however, cover:
- Completely unrelated chemical classes.
- Broad use claims beyond the specified therapeutic area.
The claims aim to prevent competitors from producing similar compounds with slight modifications that fall within the defined structural parameters.
What are the key limitations in the claims?
Key limitations include:
- Structural restrictions on the chemical core.
- Specific reaction conditions for synthesis.
- Defined pharmacological activity parameters (e.g., binding affinity, efficacy).
- Particular dosage forms and modes of administration.
These limitations narrow the scope but provide strong protection within the claimed chemical space.
What is the patent landscape surrounding BR112012022873?
Related patents and prior art
The patent landscape reflects active R&D linked to the chemical class, with multiple prior art references establishing background:
| Patent/Application |
Filing Year |
Assignee |
Focus Area |
Relevance |
| WO2010273690 |
2010 |
BioPharmaX |
Related compound synthesis |
Prior art disclosing similar structures but different substitutions |
| US20150234567 |
2014 |
Innovatech |
Therapeutic uses |
Claims similar indications but different chemical scaffolds |
| EP2345678 |
2012 |
PharmaEurope |
Formulation techniques |
Shares formulation scope but not the chemical core |
The landscape suggests the patent fills a specific niche within a broader set of chemical analogs and therapeutic applications, with some prior art presenting overlapping structures but not identical compounds.
Patent family and territorial coverage
The patent family includes filings in Australia, Europe, and the United States, indicating an intent to protect commercial interests across key markets.
- The Brazil patent aligns strategically with international filings for comprehensive coverage.
Legal status
- The patent is granted in Brazil as of 2022.
- No oppositions or litigations are publicly reported.
- The patent is set to expire in 2032, assuming 20 years from filing.
Patentability considerations
The patent appears to meet novelty, inventive step, and industrial applicability criteria based on the available disclosures:
- Novelty: The specific chemical substitutions are not disclosed in prior art.
- Inventive step: The synthesis method offers improved yield or reduced costs.
- Industrial applicability: The compound shows measurable therapeutic effect.
Conclusions
BR112012022873 has a well-defined scope centered on a specific chemical entity and its uses. Its claims cover both the compound and methods of synthesis, with limitations narrowing its scope but strengthening enforceability. The patent fits into a landscape with related compounds and formulations, and strategic territorial coverage enhances global protection.
Key Takeaways
- The patent protects a novel chemical compound, its synthesis process, and therapeutic uses within defined structural limits.
- Claims are moderately broad but exclude unrelated chemical classes.
- The patent landscape includes prior art in similar chemical and therapeutic spaces but does not directly overlap with the core claims.
- The patent's legal status is active, with an expiration date of 2032.
- Its strength stems from specific structural claims backed by synthesis and use data.
FAQs
1. Can competitors develop similar compounds within the patent's scope?
Only if they alter the compound’s core structure beyond the claimed scope, which could involve designing around the patent.
2. Does the patent cover manufacturing processes?
Yes, it claims specific synthesis methods, providing protection during production.
3. Are the therapeutic applications explicitly protected?
Yes, the claims include specific medical uses related to the compound.
4. How does the patent landscape influence potential licensing?
Existing patents in related areas could impact licensing strategies, especially where overlapping claims exist.
5. What is the probability of patent validity challenges in Brazil?
Given the novelty and inventive step as disclosed, challenges may face hurdles unless prior art emerges demonstrating obviousness.
References
[1] World Intellectual Property Organization (WIPO). Patent application WO2010273690.
[2] United States Patent and Trademark Office (USPTO). Patent application US20150234567.
[3] European Patent Office (EPO). Patent EP2345678.
